chartexchange

BBIO
BridgeBio Pharma, Inc. Common Stock
stockNASDAQ

Market OpenNov 16, 2026 10:38:31 AM EST
78.21USD-0.115%(-0.09)145,141
Pre-marketNov 16, 2026 8:38:30 AM EST
78.45USD+0.192%(+0.15)
78.08Bid78.23Ask0.15Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Palo Alto, CA, USA
Previous Close
$78.30
Beta
0.96
52-Week High
$93.42 2026-07-09
52-Week Low
$62.50 2026-06-02
SMA 50
$69.98
SMA 200
$72.69
Avg. Vol 10D
2.92M
Avg. Vol 30D
2.85M
Avg. Vol 90D
2.59M
Relative Vol
0.05
194.80M
166.51M
20,846,164
0.4100%
3,200,000
96,639
BBIO Profile

we focus on accelerating and maximizing value in early-stage, genetic disease assets by applying our management expertise and proprietary platform. our team picks the right assets based on our systematic mapping of the genetic disease landscape, and develops those assets with the right approach, supporting r&d with expert capabilities and placing them in a value maximizing corporate structure.

BBIO Performance
PeriodPriceDateChangeBeta
1W77.932026-11-09+0.24%0.769
1M66.392026-10-16+17.66%0.912
3M79.892026-08-17-2.22%0.672
6M66.132026-05-15+18.12%0.613
1Y66.902025-11-17+16.76%0.964
2Y23.722024-11-15+229.32%—
5Y47.252021-11-16+65.32%1.506
BBIO Stock Summary

BridgeBio Pharma, Inc. Common Stock (NASDAQ:BBIO) stock price today is $78.12, and today's volume is 142,033. BBIO is down 0.236% today. The 30 day average volume is 2.85M. BBIO market cap is $15.22B with 194.80M shares outstanding.